Amprius Technologies (NYSE:AMPX) Shares Down 2.8% – Should You Sell?

Amprius Technologies, Inc. (NYSE:AMPXGet Free Report)’s share price dropped 2.8% during mid-day trading on Tuesday . The company traded as low as $17.23 and last traded at $17.87. Approximately 7,614,360 shares changed hands during mid-day trading, a decline of 13% from the average daily volume of 8,786,577 shares. The stock had previously closed at $18.39.

Wall Street Analyst Weigh In

AMPX has been the topic of a number of research reports. Craig Hallum boosted their price objective on Amprius Technologies from $17.00 to $21.00 and gave the company a “buy” rating in a research note on Friday, March 6th. William Blair restated an “outperform” rating on shares of Amprius Technologies in a research note on Friday, March 6th. Oppenheimer restated an “outperform” rating and issued a $17.00 price objective on shares of Amprius Technologies in a research note on Tuesday, December 23rd. Roth Mkm restated a “buy” rating and issued a $20.00 price objective (up from $16.00) on shares of Amprius Technologies in a research note on Friday, March 6th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Amprius Technologies in a research note on Wednesday, January 21st. Eight analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $19.75.

Get Our Latest Stock Analysis on Amprius Technologies

Amprius Technologies Trading Down 2.8%

The firm has a market cap of $2.45 billion, a PE ratio of -52.56 and a beta of 2.20. The stock has a fifty day simple moving average of $14.60 and a two-hundred day simple moving average of $12.37.

Amprius Technologies (NYSE:AMPXGet Free Report) last posted its earnings results on Wednesday, March 4th. The company reported ($0.01) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.03. The business had revenue of $25.23 million during the quarter, compared to analyst estimates of $22.91 million. Amprius Technologies had a negative return on equity of 24.29% and a negative net margin of 60.30%.Amprius Technologies has set its FY 2026 guidance at –0.060 EPS. As a group, sell-side analysts predict that Amprius Technologies, Inc. will post -0.45 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Kang Sun sold 1,500,000 shares of the business’s stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $15.91, for a total transaction of $23,865,000.00. Following the completion of the transaction, the director owned 1,342,400 shares of the company’s stock, valued at approximately $21,357,584. The trade was a 52.77% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CTO Constantin Ionel Stefan sold 492,827 shares of the business’s stock in a transaction dated Thursday, January 22nd. The stock was sold at an average price of $12.04, for a total value of $5,933,637.08. Following the transaction, the chief technology officer directly owned 748,696 shares of the company’s stock, valued at $9,014,299.84. The trade was a 39.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 4,140,959 shares of company stock worth $60,630,750 over the last three months. Company insiders own 12.80% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the business. Alberta Investment Management Corp purchased a new position in shares of Amprius Technologies during the fourth quarter worth about $1,001,000. Vident Advisory LLC purchased a new stake in Amprius Technologies in the fourth quarter worth approximately $107,000. Summit Securities Group LLC purchased a new stake in Amprius Technologies in the fourth quarter worth approximately $54,000. Numerai GP LLC boosted its stake in Amprius Technologies by 29.1% in the fourth quarter. Numerai GP LLC now owns 96,209 shares of the company’s stock worth $759,000 after buying an additional 21,698 shares in the last quarter. Finally, Osterweis Capital Management Inc. boosted its stake in Amprius Technologies by 142.6% in the fourth quarter. Osterweis Capital Management Inc. now owns 454,830 shares of the company’s stock worth $3,589,000 after buying an additional 267,385 shares in the last quarter. Hedge funds and other institutional investors own 5.04% of the company’s stock.

About Amprius Technologies

(Get Free Report)

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

Read More

Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.